Study of NGM831 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors

ABSTRACT: Study of NGM831 as Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumors

DISEASE(S): Carcinoma,Cervical Cancer,Melanoma,Mesothelioma,Bladder Urothelial Cancer,Pancreatic Cancer,Breast Cancer,Ovarian Cancer,Colorectal Carcinoma,Squamous Cell Carcinoma Of Head And Neck,Endocervical Cancer,Gastric Cancer,Non-small Cell Lung Cancer,Esophageal Cancer,Colorectal Neoplasms,Prostate Cancer,Renal Cell Carcinoma,Cholangiocarcinoma

PROVIDER: 2402815 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR